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Abstract Cell infection by picornaviruses leads to membrane
permeabilization. Recent evidence suggests the involvement of
the non-structural protein 2B in this process. We have recently
reported the detection of 2B porin-like activity in isolated mem-
brane^protein systems that lack other cell components. Accord-
ing to data derived from these model membranes, four self-ag-
gregated 2B monomers (i.e. tetramers) would be su⁄cient to
permeabilize a single lipid vesicle, allowing the free di¡usion
of solutes under ca. 1000 Da. Our ¢ndings also support a role
for lipids in protein oligomerization and subsequent pore open-
ing. The lipid dependence of these processes points to negatively
charged cytofacial surfaces as 2B cell membrane targets.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Picornavirus-infected cells are good model systems for eval-
uating cell membrane alterations induced by viral infection.
Picornavirus particles have components that permeabilize cells
during virus entry. Macromolecules and other small com-
pounds readily enter cells together with viral particles by a
mechanism that is still unde¢ned. After replication of the viral
genome, the plasma membrane also becomes permeable to
small solutes and ions. This late membrane alteration is ac-
complished by de novo synthesis of non-structural proteins by
the virus. During the past few years, our understanding of the
picornavirus components responsible for this late membrane
disruption and their mode of action has greatly improved. For
details on early work in this area the reader is referred to
previous reviews [1,2].
2. Late membrane changes induced by picornaviruses
Picornaviruses induce a number of structural and functional
alterations in cell membranes after infection. These alterations
include an intense remodelling of intracellular membranes
that inhibits the correct functioning of the vesicle system
[2^4]. As a consequence, glycoprotein tra⁄cking is hampered
[5]. Intracellular membrane remodelling gives rise to numer-
ous vesicles that are required for the replication of virus ge-
nomes [6^9].
The change in plasma membrane permeability to ions and
solutes is another feature that, for several years now, has also
received much attention [1,2]. As a result, this type of alter-
ation has been described in detail. Compounds of MW less
than 1000 Da are able to enter the cytoplasm from the mid
phase of infection [10^14]. This passage of molecules occurs in
both directions: from the cell interior to the culture medium
and vice versa. The alterations that take place in cytoplasmic
concentrations of monovalent cations provoke membrane de-
polarization, ¢nally leading to cell lysis [10,14,15].
3. Picornavirus proteins involved in membrane alterations
Three non-structural viral proteins, 2B, 2BC and 3A, have
the capacity to alter cell membranes when individually ex-
pressed in cells [5,16^22]. The three genes encoding these pro-
teins are clustered in the picornavirus genome, which is ex-
pressed in the form of a long polyprotein precursor that is
proteolytically cleaved by virus-encoded proteases. The 2BC
precursor is the most active protein in terms of membrane
alteration. 2BC shows certain activities that are not observed
when 2B and 2C are co-expressed [16]. Nevertheless, several
lines of evidence, including mutagenesis studies, suggest the
capacity to enhance membrane permeability resides in the 2B
moiety. Indeed, the synthesis of 2B alone disrupts membrane
permeability in mammalian cells, although less e⁄ciently than
2BC [5,17,20]. Perhaps the 2C protein serves to e⁄ciently
transport 2B to the plasma membrane. All three proteins,
2B, 2BC and 3A, enhance membrane permeability in prokary-
otic cells [22]. However, in mammalian cells it has not yet
been possible to associate 3A with this e¡ect [17]. Perhaps,
when individually expressed, this protein is retained in an
intracellular compartment [8].
Finally, 2B, 2BC and, in an even more active manner, 3A
are all able to impair glycoprotein tra⁄cking through the
vesicle system [5,16,18,19]. A component of this system lo-
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cated at the endoplasmic reticulum may be the target for these
proteins such that the Golgi apparatus becomes disorganized.
The 2B product has been described to localize at the Golgi
complex when expressed alone [23].
4. Structure of the 2B protein in membranes
Picornavirus 2B protein contains about 100 amino acids
depending on the virus species considered (Fig. 1). Two hy-
drophobic regions have been identi¢ed in the protein [2,24^
26]. At least one of these regions (poliovirus (PV)-1 2B resi-
dues 32VTSTITEKLLKNLIKIISSLVIITG55) could span the
membrane by means of a partially amphipathic cationic helix
(Figs. 1 and 2A,B). The second region (PV-1 2B residues
61TTTVLATLALLGCDASPWQWL81) is thought to be a
transmembrane domain (TMD). Hydrophobicity distribution
along the sequence seems to be functionally meaningful, since
mutations altering either the ¢rst domain’s amphipathicity or
the second domain’s hydrophobicity have been shown to in-
terfere with the ability of 2B to increase permeability
[17,20,21,25,27] and with viral RNA replication [24,25].
More recently, it has been reported that the occurrence of
both domains in Coxsackie virus (CV) 2B mediates e⁄cient
Golgi targeting and plasma membrane permeabilization [23].
The presence of the two hydrophobic regions connected
through a short stretch also suggests that in a putative oligo-
meric 2B aqueous pore, both domains would combine in each
monomer to form a hairpin ‘K-loop-K’ motif spanning the
bilayer [21,26]. In such a model, the amphipathic helix would
subsequently serve to establish the interface between the lu-
men of the aqueous pore and the hydrophobic milieu of the
membrane, and the second helix would span the bilayer as an
integral transmembrane anchor (Fig. 2C). Integral hairpins
would reverse chain direction, so that both the N- and the
C-terminal ends of the polypeptide remain at the same side of
the membrane.
The stability of the proposed 2B structure at membranes
may be analyzed according to current understanding of the
energetics of transmembrane helix insertion. Wimley and
White’s whole-residue hydrophobicity scale for partitioning
into n-octanol provides a reasonable estimate of the free en-
ergy of inserting K-helical TMDs into bilayers [28,29]. The
hydropathy plot in Fig. 2A was computed using octanol-to-
water partitioning free energies (vGow), i.e. positive values in
the plot denote a tendency to remain in the membrane-hydro-
Fig. 1. Multiple sequence alignment of picornavirus 2B protein se-
quences by CLUSTALW [48]. Conserved residues are indicated by
the dots in the bottom row, while invariant residues are denoted by
asterisks. Protein sequences: PV: poliovirus; CV: Coxsackie virus;
HRV: human rhinovirus. Boxes designate hydrophobic domains.
Fig. 2. A: Hydropathy plot revealing the hydrophobicity distribution within the PV-1 2B (primary sequence displayed in Fig. 1). For each cen-
tral amino acid, the solid line represents the sum of Wimley^White’s standard free energies of transfer (kcal/mol) from octanol to water (vGow)
in windows of 11 residues (i.e. approximately three helical turns). The development of this scale is described in [28] and its use to evaluate the
energetics of helix insertion into membranes is discussed in [29]. The dotted line corresponds to the average moment for a ¢xed N=100‡ and a
similar amino acid window. The hydrophobic moment was calculated using the Eisenberg algorithm [49] with the modi¢cation that octanol-to-
water transfer free energies for each amino acid were considered the moduli of the vectors that project from the main axes of the K-helix (see
[50] for a detailed description). The cylinders above indicate the range and position of the proposed membrane-inserting domains. For compar-
ative purposes, the length of a GPA TMD positive peak in a similar octanol-to-water free energy plot is also represented (y-axis values corre-
spond to its maximum). B: Helical model for the PV-1 2B 32VTSTITEKLLKNLIKIISSLVIITG55 sequence. Colors were graded according to
the Wimley^White octanol scale as indicated in the side panel. C: Schematic models of PV-1 2B membrane structures. In the integral hairpin
(left), the amphipathic 32^55 helix is shown with hydrophilic and hydrophobic sides in light gray and black, respectively, while the hydrophobic
61^81 helix is dark gray (according to insertion energy estimates, this structure is unlikely to be stable). The number of monomers in the trans-
membrane pore (right) was selected by mathematically modelling leakage assays (Table 1) and SDS^PAGE oligomer detection (Fig. 3). For bet-
ter appreciation of central channel structure, the putative 61^81 TMD appears empty and is drawn in dashed lines.
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carbon mimetic octanol phase. The PV-1 2B plot con¢rms the
existence of two peaks above the 0 equilibrium value. How-
ever, compared to the canonical glycophorin A (GPA) TMD
[29], 2B peaks are shorter in range (spanning six and three
residues, respectively vs. 20 residues in GPA TMD) and are
also less intense. Computing vGow values for the proposed
bilayer-spanning PV-1 2B domains suggests that: (1) the 32^
55 amino-domain would not spontaneously remain integrated
within the membrane (vGow =32.6 kcal/mol), and (2) inser-
tion of the 61^81 carboxy-domain would energetically be fa-
vored (vGow = 2.2 kcal/mol) but the per-residue vGow value,
0.1 kcal/mol, is somewhat lower than that measured for stable
anchors (V0.5 kcal/mol in GPA TMD [29]). Thus, our theo-
retical evaluation of the energy cost indicates the proposed
hydrophobic domains would not allow the stable transmem-
brane insertion of 2B, at least as isolated helical anchors (Fig.
2C).
Hydrophobicity distribution may be considered in the con-
text of an oligomeric pore. The hydrophobic moment analysis
of PV-1 2B in Fig. 2A reveals that ca. two thirds of the hydro-
phobic amino-domain would generate one side with a strong
a⁄nity for membranes if folded as an K-helix (Fig. 2B). The
V, I and L hydrophobes that are in contact with the hydro-
carbon core would contribute to the amino-domain insertion
energy to the extent of approximately 12.6 kcal/mol, or ca. 0.5
kcal/mol per residue. Thus, segregating hydrophilic residues
towards the water-¢lled lumen of a putative pore would prob-
ably ensure the stable insertion of this domain in the mem-
brane. This suggests that producing an integral amino-domain
is causally linked to the establishment of a permeating oligo-
meric pore such as the one shown in Fig. 2C. On the other
hand, stable insertion of the PV-1 2B carboxy-region seems to
be hindered by the presence of several polar residues. Ion
pairs and hydrogen-bonded polar residues are frequently
used to drive the TMD association of integral membrane
structures and constrain their conformations [30]. Similar in-
teractions might decrease the polarity of the 2B carboxy-do-
main and contribute to the stability of the integral helical
bundle. This hypothesis is to be experimentally contrasted in
the near future using model systems (see Section 5).
5. Oligomerization and pore formation by 2B in model
membranes
The ability of 2B to directly permeabilize membranes was
assessed in a model system using large unilamellar vesicles
(LUV) as substrates [26]. The experimental results point to
the ability of 2B to induce the e¥ux of encapsulated solutes
at low protein-to-lipid ratios (s 1:50 000). The molecular
weight cut-o¡ for the release of solutes was found to be ap-
proximately that of NADH (MW 660), whose Stokes radius is
about 6 AT . These ¢ndings would appear to be consistent with
the formation by viroporin 2B of a transmembrane pore that
allows the free di¡usion of small solutes. Thus, the process of
2B-induced membrane permeabilization lends itself to mathe-
matical analysis according to a pore model (Fig. 3A, Table 1
and the Appendix).
The pore model assumes that vesicle-bound peptides self-
aggregate. When an aggregate within a membrane has reached
a critical size, i.e. it consists of M peptides, a pore can be
created within the membrane, and leakage of encapsulated
molecules can occur. It is also assumed that the process of
peptide binding is rapid and once a pore has been formed in a
vesicle, all its contents will quickly leak out. Since it is usually
assumed that bound peptides do not interchange among
vesicles, this leakage must be characterized by an all-or-none
mechanism, i.e. the vesicle population will be comprised of
those not leaking and those losing their entire contents. Fur-
ther, the leakage process must end after a certain period to
give a ¢nal extent of leakage, which depends on peptide-to-
lipid ratios. The rate and extent of leakage are assumed to be
limited by the rate and extent of formation of surface aggre-
gates of M or more peptides. In most cases, surface aggrega-
tion of the peptides is not irreversible and depends on Ks =C/
D, where C and D denote on and o¡ rate constants of surface
aggregation (see Appendix).
Our calculations using the variables M (pore size) and Ks,
the degree of surface reversibility, include peptide binding and
vesicle size distribution as input variables. The ¢nal extents of
Fig. 3. Quaternary structure of PV-1 2B in membranes. A: Extent
of aqueous content release (percentage maximum leakage at
time=60 min) induced by MBP-2B from phosphatidylinositol
vesicles (ANTS/DPX assay) (circles). The solid line corresponds to
the predicted curve calculated for a number of monomers required
to permeabilize a vesicle M of 4 (see Appendix for mathematical
model description). B: Oligomerization of 2B induced by its associa-
tion with membranes. MBP-2B in solution (sol.) or mixed with
LUV (protein-to-lipid molar ratio 1:1000) was incubated for 30 min
and solubilized in SDS^PAGE sample bu¡er. The positions of the
molecular weight markers are indicated.
Table 1
Final extents of leakage induced by the 2B peptide from phosphati-
dylinositol LUV
Lipid/protein
(mol/mol)
Leakage (%)
Experimental Calculated
M=2 4 6 8
KS = 0.006 0.05 0.1 0.2
750 85 83.6 86.9 84.3 85.1
1 000 83 79.8 83.6 80.5 81.4
1 500 74 73.3 77.7 73.8 75
2 000 78 68 72.7 68.1 69.5
3 000 65 59.6 64.3 58.9 60.2
4 000 61 53.1 57.5 51.4 52.4
6 000 43 43.8 46.9 39.7 39.4
8 000 30 37.3 38.8 30.9 29.3
16 000 17 23.2 19.8 11.9 8.5
25 000 10 15.5 10.3 4.4 2.2
100 000 0 2.9 0.3 0.02 0.001
R2 = 0.96 0.98 0.97 0.97
RMSE 5.8 4 5.5 5.6
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leakage are simulated as a function of peptide/lipid ratios.
Table 1 shows experimental and calculated percentages of
¢nal extents of leakage from phosphatidylinositol LUV as a
function of this ratio. Pore size (M) was noted to vary be-
tween M=2 and M=8. Best ¢ts to the experimental results
required larger Ks values for larger M values and vice versa.
Thus, if the pore requires a small number of peptides, the
presence of vesicles with more peptides than M is compen-
sated in the calculations by a larger degree of reversibility of
peptide surface aggregation, and vice versa. A close correla-
tion between large Ks values and a large degree of irreversi-
bility of formation of peptide surface aggregates was demon-
strated for the peptides pardaxin [31], GALA [32] and the
human immunode¢ciency virus-1 (HIV-1) gp41 pretransmem-
brane sequence [33] by £uorescence assays that monitor self-
quenching and energy transfer. The results in Table 1 indicate
that best ¢tting to the experimental results is obtained for an
assumed pore size M=4, the RMSE (root mean square error)
increasing by 37.5, 40 and 45% when going from M=4 to
M=6, 8 and 2, respectively. However, in each case, the values
of R2 are close to unity, and the values of RMSE may in fact
be within the experimental error. Hence, values of M=2, 6 or
8 cannot be ruled out, despite the best ¢t for M=4. It still
remains to be tested whether the pore model is insu⁄ciently
sensitive to account for pore size in the current system, or
perhaps there is a wide pore size distribution in our case. In
the study by Parente et al. [34], in which surface aggregation
of the peptide GALA was essentially irreversible, the uncer-
tainty in the deduced pore size (M=10) was less than 2
(89M9 12), and is consistent with the size of pre-encapsu-
lated molecules that could leak out. This analysis therefore
predicts that an oligomeric form of 2B, most likely a tetramer,
is the permeating unit.
Initial evidence for 2B oligomerization was provided by
studies on PV 2B variants that interfered with the replication
of non-defective viruses [35]. Support for the idea that 2B
forms homo-oligomers came from experiments using two-hy-
brid systems [36,37]. More recently, an elegant protocol based
on £uorescence resonance energy transfer (FRET) microscopy
in living cells has added further evidence to this notion in the
case of CV 2B [38]. In a di¡erent but complementary ap-
proach, we found that non-radiant FRET between £uores-
cently labelled PV 2B-NBD and 2B-ANS occurs at the mem-
brane surface but not in solution, indicating that
oligomerization occurs in the membrane milieu [26]. Sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) analysis provided further evidence that 2B is predom-
inantly found as dimers and tetramers in membranes (Fig.
3B). This ¢nding is in good agreement with the mathematical
pore model predictions and points to tetramers as the perme-
ating units. Of note is that SDS-resistant oligomer formation
appeared to be promoted by membrane binding. Thus, mem-
brane insertion probably helps set up interactions between 2B
monomers that cannot be disrupted within the non-polar bi-
layer milieu, a requirement that must be ful¢lled to assemble
stable, functional pores.
Our ¢ndings using model membrane systems also seem to
con¢rm the prediction that pore formation by 2B is probably
concomitant to transbilayer integration (see Section 4). Recent
experimental results obtained using LUV of de¢ned composi-
tion indicate that water^membrane partitioning of soluble
MBP-2B is mainly driven by electrostatic interactions (Agirre
et al., unpublished observations). Negatively charged phos-
pholipids promote insertion and oligomerization at the level
of the membrane interface. However, the transition from sur-
face-aggregated species to permeabilizing pores seems to be
constrained by other conditions of the bilayer and speci¢c
protein residues. One bilayer property that seems to a¡ect
translocation and pore opening is the unsaturation degree of
sn-2 acyl chains [26]. While negatively charged polar heads are
probably required for surface association and coupled refold-
ing, it is likely that acyl chain unsaturation provides condi-
tions suitable for the conformational £exibility needed to per-
pendicularly insert 2B into the membrane. The same anionic
phospholipids that modulate 2B pore formation in vitro pref-
erentially localize at cytosol-facing membrane monolayers of
di¡erent organelles including the Golgi apparatus [39]. Thus,
the lipid-exerted regulation observed in model systems is ba-
sically in agreement with studies that pinpointed the Golgi
body as a 2B target organelle [19,23].
6. Concluding remarks
Experimental results from model systems appear to be con-
sistent with the formation by viroporin 2B of a transmem-
brane structure that allows free di¡usion of small solutes.
These ¢ndings support a molecular mechanism involving the
direct permeabilizing action of 2B at the cell membrane. In
monomers of the proposed membrane structure (Fig. 2C),
three elements may be distinguished, namely, an amphipathic
helix, a short connecting loop and a putative helical TMD.
These might combine to form a hairpin ‘K-loop-K’ motif able
to span the bilayer. The cationic amphipathic helix probably
mediates interactions with anionic phospholipids. Lys/Arg-
rich lytic amphipathic peptides, such as magainins or cecro-
pins, preferentially bind to and permeabilize bilayers contain-
ing anionic phospholipids [40]. The mechanisms currently pro-
posed for the formation of ‘barrel-stave’-like pores by
amphipathic sequences assume that, following rapid binding
to membranes, aggregation occurs at their surface [41^44].
According to this rationale, a pore is formed when protein
aggregates attain a critical size. Based on mathematical pore
modeling (Table 1), this basic mechanism seems to be func-
tional in the case of 2B.
The ¢nal assembly of the 2B permeating structure is likely
to require the insertion of additional sequences into the mem-
brane. Thus, 2B function is probably modulated by the sec-
ond TMD helix and connecting loop adopting an adequate
conformation and membrane topology. Short loops connect-
ing transbilayer helices are common structural motifs in the
permeating structures of channels belonging to the major in-
trinsic protein (MIP) family [45]. In addition, hydrophobic
helices fully embedded in the membrane that reverse the chain
direction have been found in channel proteins belonging to
the mechanosensitive ion channel (MscL) family [46]. Atomic
resolution of MscL proteins reveals that an amphipathic helix
in each monomer serves to establish the interface between the
lumen of the aqueous channel and the hydrophobic milieu of
the membrane. A second helix provides an integral transmem-
brane anchor. The model in Fig. 2C suggests the same struc-
tural response for the 2B sequence, a bundle integrated within
the membrane without translocation of the terminal ends of
the molecule.
Ion channels such as those found in in£uenza and HIV-1
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enveloped viruses also form homo-oligomers to create an ion
£ux across bilayers (see other articles in this issue). Remark-
ably, a membrane-embedded hairpin organization, oligomeric
state and pore diameter, comparable to those described above
for 2B, have been proposed for the membrane-inserting do-
main of Bacillus thuringiensis Cry1A toxin [47]. In summary,
PV 2B protein might use structural themes common to those
found in lytic peptides, integral channels and bacterial toxins
to assemble tetrameric aqueous pores in membranes.
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Appendix. Equations of pore model
The kinetics of irreversible aggregation was ¢rst investi-
gated by Smoluchowski [51] and later extended to reversible
aggregation [52]. The general scheme as treated in [53] is :
Xi þ XjH
Cij
Dij
X iþj ð1Þ
where Xi is the molar concentration of an aggregate of order
i ; Cij and Dij are forward and backward rate constants of
surface aggregation of the bound peptide. For simplicity
and to avoid too many parameters, the calculations assumed
Cij =C and Dij =D. Here we have used the same scheme, but
in our case Xi denotes surface concentration.
The fraction of encapsulated material that has leaked at the
plateau level is denoted by L. Due to the dependence of the
encapsulated volume on the third power of the inner diameter,
a small fraction of large vesicles can contribute signi¢cantly to
L. We consider the vesicles to consist of j=1,2,TS classes. The
distribution of vesicles according to their diameters was deter-
mined by dynamic light scattering. We set S=10 and we de-
note the fraction of encapsulated volume in vesicles of type j
by fj , j=1^10 [31^33]. Let Aij be the normalized fraction of
vesicles of size class j that contain i bound peptides, i.e.
XNj
i¼0
Aij ¼ 1 ð2Þ
in which Nj is the largest number of peptides that can bind to
a vesicle of size class j. The procedures for calculating the
quantities Aij from binding data have been described [54,55].
In the simpler case of irreversible surface aggregation of the
peptide [34] the expression for L is given by
L ¼
XS
j¼1
XNj
i¼M
Ai;j f j ð3Þ
Eq. 3 re£ects the assumption that when aggregation is irre-
versible, all the peptides within the membrane will eventually
be incorporated into a single aggregate so that all vesicles with
at least M bound peptides will eventually leak. In the more
general case of reversible surface aggregation the expression
for L becomes
L ¼
XS
j¼1
XNj
i¼M
ZðM; i; j;KSÞAi;j f j ð4Þ
in which Z(M,i,j,KS) is the probability that a vesicle of size
class j that contains i bound peptides will include an aggregate
consisting of M or more peptides and KS is given by
KS ¼ C=D ð5Þ
In the case of irreversible surface aggregation KS tends to
in¢nity. For the calculation of ¢nal extents of aggregation
only KS and the surface concentration of the peptides, X0,
are required, the latter being known from the binding mea-
surements. As in [31]
Z ¼ pM31xðM3Mpþ pÞ ð6Þ
in which p is given by [52]
p ¼ 1=ðK þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K231
p
Þ ð7Þ
where K is given by
K ¼ 1þ 1=ð4KSXoÞ ð8Þ
For an in¢nite KS the quantities K, p and Z equal unity and
Eq. 4 reduces to Eq. 3, which corresponds to irreversible sur-
face aggregation.
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